Supernus Pharmaceuticals, Inc.
SUPN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356576
No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Supernus Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 225 | 1 | 244 | +20 |
| Shares | 54.7M | 263 | 55.7M | +911.2K (+1.7%) |
| Value | $1.58B | $8.00K | $1.88B | +$300.6M (+19.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (39)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (19)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Equity & Fixed Income | 398,885 | $11.5M |
| Soleus Capital Management, L.P. | 258,100 | $7.46M |
| Millennium Management LLC | 244,223 | $7.06M |
| Aurora Investment Counsel | 41,668 | $1.21M |
| Guggenheim Capital LLC | 33,208 | $960.0K |
| SummerHaven Investment Management, LLC | 33,123 | $958.0K |
| Balyasny Asset Management LLC | 23,643 | $684.0K |
| BNP Paribas Arbitrage, SA | 23,262 | $672.7K |
| Maryland State Retirement & Pension System | 21,750 | $629.0K |
| Vident Investment Advisory, LLC | 12,919 | $374.0K |
| CWM Advisors, LLC | 7,349 | $213.0K |
| Quent Capital, LLC | 4,000 | $116.0K |
| CoreCap Advisors, LLC | 825 | $24.0K |
| Patriot Financial Group Insurance Agency, LLC | 652 | $19.0K |
| Aquatic Capital Management LLC | 200 | $6.00K |
| Geneos Wealth Management Inc. | 170 | $4.00K |
| Northwestern Mutual Wealth Management Co | 80 | $2.00K |
| Elequin Capital LP | 44 | $1.00K |
| Sageworth Trust Co of South Dakota | 26 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Supernus Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Private Capital Group, LLC | 263 | $8.00K |